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Abstract
Background: Oxidative stress and dyslipidemia play a critical role in the development of cardiovas-
cular disease (CVD). Regular intake of polyphenol-rich diets is associated with a reduced risk of CVDs. 
Methods: The present study was a pilot study with 24 healthy volunteers and was designed to deter-
mine if a 12-week administration of Cistus incanus herbal tea, containing phenolic acids and flavo-
noids, reduces cardiovascular risk factors including oxidative stress and dyslipidemia in healthy adults. 
Phenolic compounds profile and antibacterial activity of Cistus incanus infusion were also measured. 
Results: Herbal infusion led to improvement in lipid profile by increase (D4%, p = 0.033) high-density 
lipoprotein cholesterol concentration and decrease triglyceride (D14%, p = 0.013) concentrations. In ad-
dition, the Cistus incanus diet was associated with decreased serum concentrations of malondialdehyde 
(D16%, p < 0.01) and advanced oxidation protein products (D18%, p < 0.001). 
Conclusions: Cistus incanus administration decreases cardiovascular risk factors including oxidative 
stress and dyslipidemia and this action supports the idea of using Cistus incanus tea on a daily basis as 
an effective dietary component for prevention of atherosclerotic CVD. (Cardiol J XXXX; XX, X: xx–xx)
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Introduction
Cistus incanus, a genus belonging to the family 
of Cistaceae, provides a rich source of polyphenols 
and various Cistus species herbal teas have been 
used in folk medicine for treatment of diarrhea, 
fever, and skin disorders. It also has antispasmodic, 
anti-inflammatory and antimicrobial agents [1]. 
Currently, numerous producers offer Cistus in-
canus herbal infusion (Cistus tea) or dietary supple-
ments consisting of this plant material, or extracts 
of it. These products are especially promoted with 
regard to a high content and diverse profile of 
polyphenolic substances with strong antioxidant 
activity [2]. It has been proposed that polyphenols 
can act as antioxidants by suppression of reac-
tive species formation through enzyme inhibition 
or the sequestration of trace elements involved 
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in the production of free radicals [3]. Reactive 
oxygen species are involved in pathogenesis of 
diverse human diseases which play a particular 
role in cardiovascular diseases [4, 5]. Polyphenols 
are able to attenuate the oxidation of low-density 
lipoproteins (LDL), possess vasodilatory and anti-
inflammatory activity, and modulate lipid metabo-
lism and apoptotic processes in endothelium [6]. 
It has been suggested that most of these effects 
are a consequence of the antioxidant properties of 
polyphenols; however, other mechanisms based on 
their interaction with molecular signaling pathways 
may be involved [2, 7].
Epidemiological studies provide evidence for 
an inverse relationship between the consumption 
of polyphenolic substance-rich foods and cardio-
vascular complications [8]; however, most of the 
epidemiological studies aimed at investigating car-
diovascular benefits of polyphenols have concerned 
tea, red wine, coca and polyphenol-rich fruits 
such as grapes. Furthermore, although there are 
numerous studies evaluating the composition and 
antioxidant capacities of Cistus infusion, however, 
clinical studies focused on the influence of Cistus 
incanus on oxidation balance and cardiovascular 
risk factors are limited [9]. Thus, the purpose of 
the present study was to investigate the impact of 
a 3-month supplement of commercially available 
Cistus incanus tea on oxidative stress markers 
and lipid profile in healthy adults. Additionally, the 
phenolic compounds profile was determined as 
well as antibacterial activity of when using Cistus 
incanus aqueous infusions.
Methods
Study subjects
A total of 24 healthy adults were recruited 
for the study. All procedures performed in studies 
involving human participants were in accordance 
with the 1964 Helsinki declaration and were ap-
proved by the Medical Ethics Committee of Medi-
cal University of Gdansk. All participants provided 
written informed consent.
During the interview, sociodemographic and 
clinical information was collected. The sociode-
mographic data included age, and gender. Clinical 
variables included vascular risk factors: smoking 
status, alcohol intake, physical activity, lifestyle, 
and dietary habits. All participants were non-
smoking and were sedentary or moderately physi-
cally active (at least 2 times a week). All volunteers 
were instructed not to change their diet or physical 
activity during the study. The exclusion criteria 
were: chronic disease, current use of prescribed 
pharmaceuticals, intense physical activity (up to 
3 times a week) and a body mass index (BMI) 
greater than 25 kg/m2. The study period was 
12 weeks, during which participants would intake 
a Cistus incanus infusion 3 times a day (portion of 
2 g of dry tea per day reinfused 3 times in 250 mL 
of boiling water for 3 min). Dietary compliance was 
assessed using daily study records completed by 
the participants.
Analysis of blood samples from subjects
The peripheral fasting blood samples were 
collected before (baseline) and after 6 and 
12 weeks of Cistus incanus infusion administra-
tion. The serum was separated by centrifugation 
at 1000×g for 15 min and stored at –80°C pending 
analysis. Total cholesterol (TC) and triglycerides 
(TG) were measured by standard enzymatic col-
orimetric tests (Pointe Scientific Poland). High 
density lipoproteins (HDLs) were isolated by 
precipitation of apolipoprotein B (apoB)-containing 
lipoproteins with dextran sulfate 50000/Mg2+ 
reagent and HDL cholesterol (HDL-C) was deter-
mined enzymatically. LDL cholesterol (LDL-C) 
concentration was calculated using the Friedewald 
formula. Paraoxonase (PONase) and arylesterase 
(AREase) activities of paraoxonase-1 (PON-1) were 
measured based on paraoxon and phenyl acetate 
hydrolysis, respectively [10, 11]. Malondialdehyde 
(MDA) concentration was analyzed by fluorescence 
spectroscopy using a modified thiobarbituric acid-
reactive substance [12]. Advanced oxidative pro-
tein product (AOPP) determination was performed 
based on spectrophotometric detection [13].
Plant material 
The Cistus incanus herb was purchased from 
a manufacturer in Poland (herbal manufacture AS-
TRON Józef Tabor). According to the manufacture 
information, the shrub grows in the Mediterranean 
Region of Turkey around the city of Antalya, and the 
shrub’s leaves are harvested from May to August.
Determination of total polyphenols  
and antioxidant activity 
The leaves (1.00 g) were brewed with 100 mL 
of boiling and deionized water for 15 min and 
the procedure was repeated two times to finally 
produce the first, second and third infusion. The 
Folin-Ciocalteu method was used for total phe-
nolic content (TPC) determination [14]. The 
method described in the European Pharmacopeia 
monograph for Betulae folium was used for total 
2 www.cardiologyjournal.org
Cardiology Journal XXXX, Vol. XX, No. X
flavonoid content (TFC) determination [15]. The 
total phenolic acid content was determined us-
ing the spectrophotometric method with Arnov’s 
reagent according to procedures described in the 
Polish Pharmacopoeia [16]. L-ascorbic acid (AA) 
was determined by spectrophotometric method 
[17]. 2,2-diphenyl-1-picrylhydrazyl radical (DPPH) 
scavenging assay [18] and ferric ion reducing an-
tioxidant power (FRAP) assay [19] were used to 
determine the reducing antioxidant power of the 
Cistus incanus infusions.
Chromatographic analysis: HPLC conditions
Before HPLC analysis, all the infusions 
were filtered through a 0.2 μm nylon filter film 
(Mecherey, Nagel, Germany) and 20 μL of the 
filtrate was injected into the HPLC system. Chro-
matographic separation and quantitation of phenolic 
compounds (gallic, caffeic, chlorogenic, syringic, 
vanillic, p-coumaric, elagic and ferulic acids, and 
rutin, isoquercetin, quercetin, myricetin, kaemp-
ferol, and luteolin 7-glucoside) were performed 
on a Hypersil Gold C18 column (250 × 4.6 mm, 
5 μm particles, Thermo Scientific, Runcorn, UK) 
maintained at 35°C, using acetonitrile — 0.2% 
trifluoroacetic acid solution and water — 0.2% 
trifluoroacetic acid solution as the mobile phase 
using a gradient program and monitoring system 
as previously described [20].
Antibacterial activity 
A sample of Cistus incanus (2.5 g) was infused 
three times with 50 mL of boiling, deionised water 
for 15 min to produce the first, second, and third in-
fusion. The minimal inhibitory concentration (MIC) 
and minimal bactericidal concentration (MBC) of 
all the infusions were assessed by the micro-broth 
dilution method according to the EUCAST (Euro-
pean Committee for Antimicrobial Susceptibility 
Testing) and CLSI (Clinical and Laboratory Stand-
ards Institute) reference procedures. Assays were 
carried out against selected reference and clini-
cal strains Gram-positive: Staphylococcus aureus 
ATCC 6538, methicillin-resistant Staphylococcus 
aureus 12,673 (clinical isolates), Staphylococcus 
epidermidis ATCC 14,990, methicillin-resistant 
Staphylococcus epidermidis (clinical isolates), Strep-
tococcus pneumoniae (clinical isolates), Bacillus 
subtilis ATCC 6633, and Gram-negative bacteria 
Escherichia coli ATCC 8739. Clinical isolates were 
obtained from St. Albert Specialist Hospital in 
Gdansk (Independent Public Health Care Facility 
in Gdansk, Poland).
Statistical analysis 
Statistical analysis was performed using the 
Statistica software package (STATISTICA 12.0 
Statsoft Poland). The Shapiro-Wilk test was used to 
establish data distributions. Continuous variables 
were expressed as a mean ± standard deviation or 
median with 25th and 75th percentiles (interquartile 
range [IQR]). Potential differences among the 
results were analyzed using a repeated-measures 
ANOVA with the Tukey multiple comparison test 
for parametric variables and with the Friedman test 
for non-parametric data. Statistical significance was 
set at p < 0.05.
Results
The study participants were aged between 
23 and 25 years old (21 females and 3 males) with 
a body mass index (BMI) of 21.3 ± 0.6 kg/m2. There 
were no significant differences in BMI during the 
12-week period of dietary modification.
Lipid profile and serum oxidative  
stress parameters
Analysis of the lipid profile revealed a signifi-
cant increase in HDL-C concentration (47 ± 9 vs. 
50 ± 9 mg/dL; p = 0.033) and a decrease in TG 
levels (71 ± 23 vs. 60 ± 24 mg/dL; p = 0.013), 
there were no changes in the concentration of TC 
and LDL-C over 12 weeks of follow up (Fig. 1). 
The concentrations of serum oxidative stress 
markers — MDA and AOPP were measured before 
and after 6 and 12 weeks of Cistus incanus herbal 
tea supplementation. A reduction of about 16% in 
MDA concentration (20 ± 5.5 vs. 15 ± 4.9 μmol/L; 
p < 0.01) and 18% in AOPP concentration (66 ± 
18 vs. 53 ± 17 μmol/L; p < 0.001) after the first 
6 weeks of Cistus incanus intake was observed 
(Fig. 2). The following 6 weeks of supplementation 
showed no further significant changes in concentra-
tions of MDA (15 ± 4.9 vs. 15 ± 4.5 μmol/L) and 
AOPP (53 ± 17 vs. 54 ± 16 μmol/L). There was 
no significant effect of Cistus infusion on PON-1 
activities, measured both toward paraoxon and 
phenyl acetate as substrates (Table 1).
Phenolic content and antioxidant capacity 
Total phenolic acids (TPC), flavonoids (TFC), 
phenolic acids (TPAC) and L-ascorbic acid (AA) 
contents in multiple aqueous extractions of Cis-
tus incanus were determined, the results are 
presented in Table 2. Analysis of variance and the 
Duncan multiple range test indicate a significant 
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influence of multiple extractions (p < 0.05) on 
TPC, TFC, TPAC, and AA. The effects of multiple 
extractions on the phenolic acids and flavonoids 
content of Cistus infusions are presented in Tables 
3 and 4, respectively. Among phenolic acids the 
most abundant was gallic acid. Caffeic and vanilic 
acids were determined only in the first extraction, 
while chlorogenic, syringic and ferulic acids were 
not found. In the case of flavonoids, myricetin 
and isoquercetin were the most abundant, while 
keampferol was not determined. According to the 
TPC, TFC, TPAC and AA the content of phenolic 
acids and flavonoids also gradually decreased and 
the lowest content was obtained in the third extract 
of Cistus infusions. The antioxidant capacities of 
Cistus incanus evaluated by DPPH and FRAP as-
says exhibited a gradual decrease and the lowest 
activity was obtained in the third extract of Cistus 
infusions (Table 5).
Antibacterial activity 
To investigate the possible antibacterial activ-
ity of aqueous Cistus incanus, Gram-positive and 
Gram-negative bacteria strains were used. The 
values of MIC and MBC are shown in Table 6. For 
all Gram-positive bacteria, the MIC value was 
4 mg/mL and the MBC ranged from 8 to 32 mg/mL, 
suggesting a bacteriostatic effect. There was no 
difference in antimicrobial activity of the extracts 
between successive infusions. No activity was 
demonstrated against Gram-negative bacteria in 
the tested concentration range. 
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Figure 1. Serum concentrations of total cholesterol (TC) (A), low density lipoprotein cholesterol (LDL-C) (B), high den-
sity lipoprotein cholesterol (HDL-C) (C), and triglycerides (TG) (D); at baseline, after 6- and 12-weeks supplementation 
with Cistus incanus herbal tea. All values represent means ± standard error. Data were analyzed using a repeated-
measures ANOVA (*) with the Tukey post hoc test (**) to determine where differences existed. 
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Figure 2. Serum concentrations of malondialdehyde (MDA) (A) and advanced oxidative protein products (AOPP) (B); 
at baseline, after 6- and 12-weeks supplementation with Cistus incanus herbal tea. All values represent means ± 
standard error. Data were analysed using a repeated-measures ANOVA (*) with the Tukey multiple comparison test 
(**) to determine where differences existed.
Baseline Baseline6 weeks
supplementation
6 weeks
supplementation
12 weeks
supplementation
12 weeks
supplementation
*p < 0.001
**p < 0.001
**p < 0.001
**p < 0.001
**p < 0.001
*p < 0.001
13 44
14
50
48
46
15
52
16 54
56
58
17
6018
62
19
68
66
64
20
7021
72
22
74
23 76A B
M
D
A
 [
mm
o
l/
d
L
]
A
O
P
P
 [
mm
o
l/
d
L
]
Table 3. The contents of phenolic acids-gallic (GA), caffeic (CA), chlorogenic (CGA), syringic (SA),  
vanillic (VA), para-coumaric (pCA), elagic (EA), ferulic (FA) in Cistus incanus multiple aqueous  
extractions.
Extraction GA  
[µg/g dw]
CA  
[µg/g dw]
CGA  
[µg/g dw]
SA  
[µg/g dw]
VA  
[µg/g dw]
pCA  
[µg/g dw]
EA  
[µg/g dw]
FA  
[µg/g dw]
First 496.4 ± 3.1 38.5 ± 1.4 ND ND 26.2 ± 1.2 126.5 ± 2.3 243.6 ± 2.7 ND
Second 340.3 ± 2.4 ND ND ND ND 76.1 ± 2.0 185.3 ± 1.8 ND
Third 260.6 ± 2.1 ND ND ND ND 60.2 ± 1.0 143.4 ± 1.1 ND
Values are expressed as means ± standard deviation (n = 3); ND — not detectable
Limits of detection [μg/mL]: CA — 3.2, CGA — 2.0, SA — 3.8, VA — 7.3, FA — 2.9
Table 2. Total phenolic (TPC) and flavonoids (TFC), phenolic acids (TPAC) and L-ascorbic acid (AA) 
contents in Cistus incanus multiple aqueous extractions.
Extraction TPC  
[mg GAE/g dw]
TFC  
[mg QE/g dw]
TPAC  
[mg CAE/g dw]
AA  
[mg AA/g dw]
First 98.5 ± 1.3 2.5 ± 0.4 10.9 ± 0.9 0.86 ± 0.05
Second 85.3 ± 1.1 1.8 ± 0.5 9.0 ± 1.1 0.76 ± 0.02
Third 78.5 ± 1.0 1.6 ± 0.9 7.7± 1.8 0.67 ± 0.03
Values are expressed as means ± standard deviation (n = 3); mg GAE/g dw — mg of gallic acid equivalent per gram dry weigh; mg QE/g dw 
— mg of quercetin equivalent per gram dry weight; mg CAE/g dw — mg of caffeic acid equivalent per gram dry weight; mg AA/g/dw — mg  
of L-ascorbic acid per gram dry weight
Table 1. Paraoxonase-1 (PON-1) activity before, after 6 and 12 weeks of Cistus incanus herbal tea  
supplementation.
PON-1 activity Baseline 6 weeks 12 weeks
Median IQR Median IQR Median IQR
Paraoxonase [U/L] 104 75–187 94 73–193 102 78–195
Arylesterease [kU/L] 211 172–236 211 176–234 206 158–233
*Potential differences among the results were analyzed using the Friedman test; IQR — interquartile range
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Discussion
The presented results demonstrate that sys-
tematic administration of aqueous extract of Cis-
tus incanus influences the lipid profile in healthy 
adults. According to available research, this is the 
first study to investigate any association between 
a serum oxidative stress biomarker and a Cistus 
incanus tea-rich diet. The in vivo studies of bio-
logical activity of polyphenols seem be especially 
important because polyphenols are extensively 
metabolized in the body and their bioavailability 
may be different. Thus, the relation between the 
quantity of polyphenols in food and their in vivo 
activity is not obvious [7, 21]. 
Excessive uncontrolled lipid and protein oxi-
dation is associated with pathogenesis of various 
diseases such as atherosclerosis, osteoporosis, 
cancer, Alzheimer’s, and Parkinson’s diseases. 
Among them atherosclerosis is the underlying 
condition in most cardiovascular diseases being 
the leading cause of death in Western socie-
ties. Oxidation of LDLs is a key mechanism in 
this chronic systematic disease, leading to the 
development and progression of the disease. 
A number of animal studies have demonstrated 
that consumption of polyphenols limits the inci-
dence of coronary heart disease and an abundance 
Table 5.  The antioxidant capacities of Cistus in-
canus multiple aqueous extractions evaluated by 
DPPH and FRAP assays.
Extraction DPPH  
[µmol TE/g dw]
FRAP  
[mmol Fe2+/g dw]
First 82.5 ± 1.8 112.6 ± 2.0
Second 77.0 ± 1.9 100.3 ± 1.4
Third 72.6 ± 1.0 96.6 ± 1.2
Values are expressed as means ± standard deviation in μg/g dw  
(n = 3); DPPH — 2,2-diphenyl-1-picrylhydrazyl radical; FRAP — ferric 
reducing/antioxidant power; μmol TE/g dw — μmol Trolox equiva-
lent per gram dry weight; mmol Fe2+/g dw — mmol ion equivalents 
per gram dry weight
Table 4. The content of flavonoids: rutin (RUT), isoquercetin (IsoQ), quercetin (QUE), myricetin (MYR), 
kaempferol (KAE), 7-luteolin glucoside (L-7gl) in Cistus incanus multiple aqueous extractions.
Extraction RUT  
[µg/g dw]
IsoQ  
[µg/g dw]
QUE  
[µg/g dw]
MYR  
[µg/g dw]
KAE  
[µg/g dw]
L-7gl  
[µg/g dw]
First 548.2 ± 3.3 910.6 ± 3.0 826.5 ± 3.5 1638.4 ± 4.6 ND 432.5 ± 2.7
Second 320.4 ± 3.2 760.3 ± 3.5 780.7 ± 3.1 1054.0 ± 4.0 ND 248.8 ± 3.3
Third 280.0 ± 2.6 222.1 ± 2.4 650.7 ± 2.1 867.2 ± 3.0 ND 178.9 ± 3.5
Values are expressed as means ± standard deviation (n = 3); ND — not detectable
Limit of detection for KAE — 1.7 μg/mL
Table 6. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values 
of Cistus incanus multiple aqueous extracts against reference strain and clinical isolates.
Microorganisms ATCC No. MIC [mg/mL] MBC [mg/mL]
First  
extraction
Second  
extraction
Third  
extraction
First  
extraction
Second  
extraction
Third  
extraction
Staphylococcus aureus 6538 4 4 4 8 8 8
Methicillin-resistant 
Staphylococcus aureus 
12673 4 4 4 32 32 16
Staphylococcus  
epidermidis 
14990 4 4 4 8 8 8
Methicillin-resistant 
Staphylococcus  
epidermidis 
13199 4 4 4 16 16 16
Streptococcus  
pneumoniae
Clinical  
isolate
4 4 4 NA NA NA
Bacillus subtilis 6633 4 4 4 8 8 8
Escherichia coli 8739 NA NA NA NA NA NA
ATCC — American Type Culture Collection; NA — no antimicrobial activity
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of literature has shown that polyphenols effec-
tively protect LDL against oxidation ex vivo [4, 
5, 22]. In the present study, assessing the effect 
of herbal supplements on oxidative stress param-
eters, it was found that the concentration of MDA 
as a marker of lipid peroxidation, and AOPP as 
a marker of protein peroxidation, decreased 
significantly after 6 weeks of use. Data in the 
literature concerning the impact of phenolic 
compounds from Cistus incanus extract on oxi-
dative balance is poor. However, the increase in 
antioxidative capacity of plasma following the 
consumption of other polyphenol-rich food has 
been widely described. Litvinov et al. [23] showed 
that even a single dose of tea with or without milk 
increases plasma antioxidant activity. Increased 
antioxidative capacity was also observed as 
a consequence of the systematic intake of wine 
and beer, as well as fruit and vegetables rich in 
polyphenols such as strawberries and spinach 
[2]. It has also been shown that the consumption 
of polyphenol-rich blackcurrant and apple juice 
by healthy volunteers significantly reduced the 
plasma concentrations of MDA [24]. However, 
data from the impact of red wine consumption on 
lipid peroxidation is ambiguous [25–27]. 
Potent inhibition of LDL oxidation is, how-
ever, not only suggested by the protective effects 
of polyphenols against cardiovascular disease. 
Polyphenols have also been shown to inhibit the 
invasion and proliferation of smooth muscle cells 
in the arterial wall, inhibit platelet aggregation, and 
improve endothelial dysfunction in animal models 
[28, 29]. Polyphenols may also modify the lipid 
profile. A significant increase in plasma HDL-C 
was observed in healthy adults when administered 
drinks containing coca for 12 weeks [30]. Adminis-
tration of Bergamot polyphenol extract for 30 days 
also resulted in increased HDL-C and decreased 
triglyceride concentrations in hyperlipidemic 
patients [31].  Data from the study about rich-in-
polyphenol teas are, however, contradictory. One 
meta-analysis found no effects of black tea on TC 
and serum concentrations of LDL-C and HDL-C 
[32], while another concluded that consumption of 
black tea lowered LDL-C, especially in subjects at 
high cardiovascular risk [33]. In the current study 
a significant increase in HDL-C concentration 
was observed and a decrease in TG level during 
a 3-month supplementation with Cistus incanus 
was also recorded. These results suggest a posi-
tive impact on lipid metabolism and confirms 
a very wide range of potential pro-health attributes 
of Cistus incanus.
Several studies have attempted to eluci-
date the phenolic composition of Cistus incanus 
[34–37]. Viapiana et al. [20] in their earlier work 
assessed the phenolic profile and antioxidant 
capacity of aqueous extract of 15 commercially 
available samples of Cistus incanus, and showed 
that the place of the origin was the main factor in 
differentiating the Cistus incanus samples. The 
extracts obtained from Turkish Cistus incanus 
were the richest in total phenolic compounds 
(TPC), flavonoids (TFC), phenolic acid (TPAC) 
and ascorbic acid (AA). Cistus incanus used in the 
present study came from Mediterranean part of 
Turkey around the city of Antalya and — similar 
to previously analyzed samples from Turkish 
Cistus incanus — myricetin, quercetin, and 
isoquercetin were the most abundant phenolic 
compounds, with a content exceeding 800 μg/g 
dw. Gallic acid and rutin were found at the level 
ca. 500 μg/g dw, and 7-luteolin glucoside came 
in ca. 400 μg/g dw. 
The antioxidant activities, evaluated with 
DPPH and FRAP also showed similar results 
to the previous published range of antioxidative 
capability of samples from Turkish Cistus incanus 
[20]. Deng et al. [38] determined the antioxi-
dant capacities and total phenolic contents of 56 
vegetables, and the levels of TPC, DPPH and 
FRAP values were lower than results obtained 
in this study, which seems to confirm Cistus in-
canus tea as a good source of polyphenols in the 
human diet. However, Konieczynski et al. [39] 
determined individual phenolic compounds in 
green and black teas and their total levels were 
higher than that obtained in the Cistus incanus 
infusions. In earlier studies it was established 
that aqueous extracts of Cistus exhibit good an-
timicrobial activity, particularly against bacteria 
G (+), and to a much lesser extent, affecting the 
growth of bacteria G (–) [20, 37]. Therefore, in 
this work it was decided to perform tests mainly 
in relation to selected G (+) bacteria. The pres-
ent results confirmed good antimicrobial activity 
against bacteria G (+). Once again, no activity 
was demonstrated against G (–) bacteria in the 
tested concentration range. 
According to the commercially included in-
structions, volunteers participating in the pro-
ject reinfused the daily portion of Cistus incanus 
3 times. The study of the multiple extractions ef-
fect on the phenolic acids and flavonoids content 
revealed that Cistus incanus tea can be re-infused; 
however, the first infusion showed higher levels 
of polyphenols and antioxidant activities, which 
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gradually decreased in later infusions. There was 
no difference in antimicrobial activity of the ex-
tracts on successive infusions.
Conclusions
This study supports the idea that Cistus in-
canus tea can be a valuable source of polyphenols 
in the human diet. The supplementations with the 
commercially available Turkish Cistus incanus tea 
had a positive impact on oxidative stress markers 
and lipids profile, allowing us to suggest that there 
are a wide range of pro-health properties of Cistus 
incanus, and beneficial effects on the cardiovascu-
lar system may be added.
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